Elon Musk expects to start human trials of Neuralink's brain chip in 6 months (Reuters)
Elon Musk's brain implant company, Neuralink, announced Friday that it has received approval from the U.S. Food and Drug Administration (FDA) to carry out its first clinical trial of brain implants in humans.
The company tweeted, "This approval is an important first step that will one day allow our technology to help many people." The U.S. Food and Drug Administration has yet to respond to the report.
Neuralink tweeted: "Delighted to announce approval for our first clinical trial."
Elon Musk (Photo by Getty Images, Win McNamee)
Since 2019, the company's founder, Elon Musk, has predicted on at least four occasions that it chose to begin clinical trials. In practice, however, it was only in early 2022 that she submitted an application for FDA approval and was rejected.
Musk predicts that brain implants could cure obesity, autism, depression and schizophrenia, among others. Late last year, he said he was so confident in the safety of the implants that he would be willing to implant them in his children.
- news
- World News
Tags
- Elon Musk
- Human trials
- United States
